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Abstract
Background: Metastasis is the leading cause of  cancer deaths. Migration of  tumor cells is an important stage in metastasis. 
Therefore, recent studies have focused on clarifying migration and migration-dependent cell functions such as angiogenesis, 
wound healing, and invasion.
Objectives: In the present study, we aimed to investigate the effect of  acetazolamide, which is a classical carbonic anhydrase 
inhibitor, on the cell viability, migration, and colony forming capacity of  human LS174T colorectal cancer cells. 
Methods: Three different cell culture techniques (MTT test, wound healing and clonogenic assay) were performed in this in 
vitro study on colorectal cancer cells.
Results: Acetazolamide reduced the cell viability, migration and colony formation ability of  cells depending on dose. There 
was no significant difference between the cells treated with acetazolamide with 1 μM dose and the control. However, it can be 
concluded that acetazolamide exerts its effect on human colorectal cancer cells at 10-1000 µM concentrations.
Conclusion: Acetazolamide was observed to significantly inhibit the cell viability, colony forming capacity, and migration ability 
in the culture medium of  LS174T cells. This inhibitor effect of  acetazolamide was observed to be dependent on the concentra-
tion in medium. 
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Introduction
Among all cancer types, colorectal cancer is the third most 
common cancer type in males (0.7 million, 10.1% of  all 
cancer types) and the second most common cancer type 
in females by following the breast cancer (0.61 million, 
9.2% of  all cancer types). Colorectal cancer mortality rate 
ranks the fourth in males and third in females.1
The most common cause of  death is metastasis in cancer 
patients. Therefore, metastasis has become a focus both 
in scientific and clinical researches in cancer patients. 
Though great progresses have been made in clarifying 
the molecular and cellular basis of  cancer-related deaths 
in recent years. The underlying mechanism of  metastat-
ic disease has still not been fully clarified, and methods 
for preventing metastasis have remained limited.2 Can-
cer cells acquire the ability to move through their own 
motility in tissues during invasion and metastasis. The 
control of  cancer cell migration is a major problem in 
tumor treatment. Cancer cell migration has also a critical 
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importance in several physiological and pathological pro-
cesses including tumor growth, wound healing, immunity, 
angiogenesis and metastasis.3 Due to their rapid metabo-
lism and split rate, cancer cells need more oxygen and nu-
trient than other cells. New blood vessels (angiogenesis) 
are formed to meet this need. Tumor blood vessels are 
enlarged and pores with wide gap junctions are formed in 
endothelial cells depending on the imbalance in the levels 
of  angiogenic regulators.1
Aquaporins are small transmembrane water channel pro-
teins found in different human tissues.4 Most of  the AQPs 
are distributed in epithelium and endothelium as well as 
in other cells and tissues such as erythrocytes, astrocytes, 
adipocytes and skeletal muscle.5 A significant correlation 
was found between the severity and prognosis of  histo-
logical tumors of  cancer patients and AQP expression in 
several cancer types. Therefore, AQPs have been suggest-
ed to be used as therapeutic biological markers in cancer 
patients, and AQP inhibitors may be a novel therapeutic 
target in tumor cells and microvessels.4
Aquaporin-1 (AQP1) has been shown to be over-ex-
pressed in brain, lung, breast, colorectal, and ovarian 
cancers.6,7 As well as AQP1, certain types of  AQPs such 
as AQP3, AQP5 and AQP9 are expressed in colorectal 
cancer.7 There was a correlation between the over-expres-
sion of  AQP3 and tumor differentiation and metastasis 
in some patients with colon cancer.8 Furthermore, AQP5 
and AQP9 have been associated with drug resistance in 
colon cancer.9
There are also several AQP inhibitor compounds, which 
are used to inhibit biological functions of  the tumor.10-12 
Acetazolamide is one of  them and is found to inhibit the 
AQP1 expression protecting the tumor from cytotoxic 
edema through the preservation of  extracellular acidifi-
cation, and to support tumor metastasis in the glioma.12 
Acetazolamide is a potent CA inhibitor which catalyzes 
the stabilization of  carbondioxide and carbonic acid, and 
has important effects on the urine formation process, re-
absorption of  sodium bicarbonate and acid release.13 It 
reduces the tumor growth in vivo, when used as mono-
therapy and has also additive effects by delaying tumor 
growth, when used in combination with other chemo-
therapeutic compounds.14
In the present study, we aimed to investigate the effect of  
acetazolamide on the cell viability, migration, and colo-
ny forming capacity of  human LS174T colorectal cancer 
cells. We chose the LS174T colorectal cancer model in 




Preparation of  cell culture and passage
Human colon cancer cells were used in our study. LS174T 
cell line was obtained from German Cancer Research 
Center (Heidelberg, Germany). Cells were cultured in an 
incubator with 5% CO2 and 37°C temperature. RPMI-
1640 medium supplemented with 10% fetal bovine se-
rum (FBS) and L-glutamine (2 mM) was used as a cell 
medium. The cells were passaged two or three times a 
week to keep the cells in logarithmic growth phase, and 
were washed with phosphate-buffered saline (PBS) and 
trypsinized (0.25% trypsin/EDTA). Pelleted for 5 min at 
1,500 rpm and re-suspended at the desired concentration 
in RPMI-1640 medium.
Cell proliferation
Viability of  the cells was evaluated through the method 
of  staining of  living cells with MTT (3- [4,5-dimethylth-
iazol-2-yl] -2,5-diphenyltetrazolium bromide). LS174T 
cells were cultured in 96-well culture plates as being 4x103 
cells in each well (Sarstedt, Germany). Acetazolamide was 
added at 1 μM, 10 μM, 100 μM, 1000 μM concentrations 
after 24 h of  incubation. 10 μL MTT (Applichem, Ger-
many) solution, which was prepared in 5 mg/mL PBS, 
was added for per well 24 h after the addition of  acetazol-
amide. 100 μL of  isopropanol/HCl solution was added 
to the plates, which were kept in the incubator for 3-4 
h, after the removal of  medium. Formazan crystals were 
made to be dissolved. Optical densities were measured 
at 570 nm wavelength by using ELISA plate reader (Bio-
Tech, USA).16,17 
In vitro wound healing assay
LS174T cells were cultured in plates as being 6x104 cells 
in each well. They were subjected to a 24 h standard incu-
bation (5% CO2, 37°C). A straight line was drawn by us-
ing a 200 μL sterile plastic pipette tip. Then, cell residues 
were removed by using RPMI-1640 medium. 0.5 mL of  
acetazolamide was added at concentrations of  1 μM, 10 
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μM, 100 μM, and 1000 μM. The wound healing effect was 
evaluated at 0, 24, 48, and 72 h through photographs.18
Clonogenic assay
A colony formation assay was performed to evaluate cell 
proliferation. Culture was made to be 500 cells for each 
of  the six well plates. Acetazolamide was added at increas-
ing concentrations (1-1000 μM) after 24 h of  incubation. 
This was carried out every 5 days. Cells were washed with 
PBS and stained with crystal violet after two weeks. Colo-
nies with more than 50 cells were counted and analyzed.19
Statistical analysis
The ImageJ 1.48 software was used to evaluate wound 
healing photos. Statistical analysis was performed using 
the SPSS version 15.0 software (SPSS Inc., Chicago, IL, 
USA), and descriptive statistics were expressed in mean ± 
standard deviation (SD). The Shapiro-Wilk normality test 
was used to evaluate whether the variables showed a nor-
mal distribution. One-way analysis of  variance (ANOVA) 
was used for the independent groups. A p value of  <0.05 
was considered statistically significant. 
Results
Cell proliferation assay
Acetazolamide administration in LS174T cell line was 
observed to inhibit the cell proliferation at all concen-
trations. According to the MTT test results, the results 
obtained at 24, 48, and 72 h were found to be statistically 
significant different (p<0.05). The inhibitory effect of  ac-
etazolamide in LS174T cell line was significant within the 




Figure 1. Survival rates of LS174T cells after the administration of acetazolamide. 
(*p<0.05; compared to the control). 
A statistically significant decrease (p<0.05) in cell viability 
was observed as the dose increased in the first 24 hours 
(1 µM; 95.1%, 10 µM; 94.8%, 100 µM; 85.7%, 1000 µM; 
81.1%). Inhibition of  cell viability was observed (p<0.05) 
at increasing concentrations after 48 hours incubation, 10 
µM; 73.8%, 100 µM; 67.5%, 1000 µM; 64.9%. When cell 
viability is assessed after 48 hours of  incubation, 1 μM 
concentration of  acetazolamide inhibited cell viability ra-
tio of  97.4% (p>0.05). After 72 hours of  incubation, the 
results were 1 µM; 97.5%, 10 µM; 84.1%, 100 µM; 79.4%, 
1000 µM; 69.8% (p<0.05).
The survival curves of  LS174T cells after acetazolamide 
administration at different doses are shown in Figure 
2. Acetazolamide showed an antiproliferative effect on 
LS174T cells due to concentration and time.
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Figure 2. Survival curves of LS174T cells following exposure to 
acetazolamide. The values represent the means ± SD. 
In vitro wound healing (scratch) assay
LS174T cells (4x103 cells in 0.5 mL) were cultured to 24 
well plates, and a straight line was drawn with a 200 μl 
pipette tip to open a cleft. After 24 h, acetazolamide was 
added. The images of  the cells were taken at 24, 48 and 
72 h (Figure 3). 
 
Figure 3. Wound healing responses of LS174T cell line following exposure to 
acetazolamide. ImageJ 1.48 software was used for the measurements. 
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In wound healing results, the cleft, which was opened at 
the first 24 and 48 h, was observed to be healed at the 
lowest level, and the ability of  cells to migrate was re-
strained. The results of  wound closure area showed that 
acetazolamide treatment improved cellular migration 




Figure 4. The width of the gaps of LS174T cells after the administration of acetazolamide. 
Clonogenic assay
LS174T cells were cultured as being 500 cells in 2 mL for 
each of  the six well plates. After 24 h, it was treated with 
acetazolamide at increasing concentrations. The treat-
ment was repeated after five days, and the test was ended 
at day 10. As a result of  the test, colonies with more than 
50 cells were counted for the LS174T cell line (Table 1). 
Discussion
Aquaporins are a family of  proteins consisting of  13 
small (~30-kDa monomers) hydrophobic integral mem-
brane water channel proteins which are involved in the 
transcellular and transepithelial water movement, fluid 
transport, and cell migration.20,21 They play a central role 
in brain water homeostasis, secretion of  exocrine glands, 
urine concentration, skin hydration, fat metabolism, and 
neural signal transduction. In addition to these, AQPs are 
also engaged in the pathogenesis of  tumor-related edema, 
tumor cell proliferation, cell migration and tumor angio-
genesis, and cancer formation.4 In recent studies, the re-
lation between AQP and cancer has been addressed.7,22-28 
AQP1 expression in plasma membrane of  HT20 colon 
cancer cells and adenovirus-mediated increased expres-
sion of  AQP1 were found to increase the plasma mem-
brane water permeability and migration rate in both 
wound healing and invasive transwell migration assays. 
Table 1. The treatment acetazolamide was reduced clonogenic survival on LS174T cells.  
Cells were treated for 24 h with increasing doses (1-1000 µM) of acetazolamide. 
 
Acetazolamide treatment Number of colonies 
counted 
Reduction of colony count 
compared to control (%) 
Control 130 - 
1 µM 100 23.1 
10 µM 75 42.8 
100 µM 59 54.7 
1000 µM 38 70.8 
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Water permeability of  AQP1 mediated plasma mem-
brane was also suggested to be of  utmost importance for 
colon cancer cell migration, and it was related to tumor 
invasion and metastasis.23 The tumor microenvironment 
includes the complex physiological networks contributing 
to the plasticity of  tumor cells and the heterogeneity of  
the tumor tissue. 
Hypoxia is an important component which produces 
intratumoral oxygen gradients. One of  the adaptive re-
sponses of  tumor cells to hypoxia is the increased ex-
pression and functional activation of  carbonic anhydrase 
IX (CA IX).4 CA IX, which is metalloprotein contain-
ing zinc, catalyzes the conversion of  carbon dioxide to 
bicarbonate ion and proton reversibly.4,29,30 Through this 
catalytic activity, CA IX contributes to the regulation of  
intracellular and extracellular pH impairments caused by 
hypoxia-induced changes in cellular metabolism produc-
ing excess acid.4 Overexpression of  CA IX is generally as-
sociated with poor prognosis and decreased disease-free 
survival after successful treatment due to its important 
role in tumor progression, acidification and metastasis in 
different types of  cancer. Therefore, it is considered as a 
prognostic indicator in oncology.29 In a previous study, 
Tülüce and colleagues found that the novel sulfonamide 
derivative CA IX inhibitor (H-4i) has more cytotoxic and 
apoptotic activity through the production of  ROS on col-
orectal cancer cells than in normal cells.30 Acetazolamide 
is one of  the sulfonamide-derived CA inhibitors. There 
are several studies suggesting that acetazolamide, which is 
used clinically in glaucoma treatment, can be also useful 
in cancer chemotherapy. It was shown to inhibit some 
carbonic anhydrase enzymes and AQPs in certain types 
of  cancer. According to some authors, acetazolamide 
can reduce the number of  invasive cells by inhibiting the 
cell proliferation.31,32 In our study, acetazolamide in con-
centrations of  10 μM and higher was found to reduce 
the number of  cells significantly, which are grown in cell 
culture plates. After acetazolamide administration, both 
the rate of  colony formation and the ability of  cells to 
migrate were observed to be reduced.
In several studies, there are some evidences with regard 
to the inhibition effect of  acetazolamide alone on inva-
sive potential of  cancer cells in vitro. Based on literature 
information it can be suggested that the inhibition of  CA 
enzymes by acetazolamide can reduce the invasive poten-
tial of  cancer cells by inhibiting the activation of  these 
matrix degrading enzymes.
Acetazolamide which was used is an inhibitor of  col-
orectal cancer-associated carbonic anhydrases (CAIX and 
CAXII) and water channel proteins (AQP1 and AQP5) in 
this study. We attempted to make the microenvironment 
of  tumor cells alkaline by suppressing the expression of  
these proteins. Migration and invasion of  the cells were 
thought to be suppressed in this way. As dose-dependent, 
acetazolamide inhibited the cell viability, migration ability, 
and ability to colonize of  cells. 
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